ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allegra, L
Right arrow Articles by Negretto, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allegra, L
Right arrow Articles by Negretto, G.
Eur Respir J 1995; 8: 1842-1846
Copyright © ERS Journals Ltd 1995


Original Articles

High altitude exposure reduces bronchial responsiveness to hypo-osmolar aerosol in lowland asthmatics

L Allegra, A Cogo, D Legnani, PL Diano, V Fasano, and GG Negretto

It is well-known that many patients with asthma undergo clinical improvement during a stay at high altitude. At high altitude, the atmospheric and climatic conditions (such as hypoxia, cold and dry air inhalation) could modify the bronchial responsiveness in asthmatics. Our study was designed to assess the difference in bronchial responsiveness to hypotonic aerosol between sea level and high altitudes in nonresident asthmatic subjects. The results were obtained during two mountaineering expeditions above 4,000 m i.e. at 4,559 m on Mt Rosa, Italy; and at 5,050 m near the Mt Everest base camp in Nepal. Eleven mild asthmatics performed standard bronchial challenges with ultrasonically nebulized distilled water (5 min inhalation, delivery 2 mL-min-1) at sea level and after staying at least 72 h at the above mentioned altitudes. The decrease in forced expiratory volume in one second (FEV1) from baseline was used as index of bronchial response. There was no significant difference in pre-challenge FEV1 between sea level and high altitude in either study. However, the bronchoconstriction response to ultrasonically nebulized distilled water was significantly reduced at high altitude in both studies. At sea level the mean FEV1 decrease was 22.2% (range 15-35%), whereas as the maximal altitude it was 6.7% (range 2-11%). Our results indicate that there is a reduction in bronchial responsiveness to hypoosmolar aerosol at high altitude. This suggests that atmospheric and climatic conditions, or physiological adaptations, via mediators such as atrial natriuretic peptide, are beneficial to patients with asthma at high altitude.


This article has been cited by other articles:


Home page
Eur Respir JHome page
A. M. Luks and E. R. Swenson
Travel to high altitude with pre-existing lung disease
Eur. Respir. J., April 1, 2007; 29(4): 770 - 792.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
S K Weiland, A Husing, D P Strachan, P Rzehak, and N Pearce
Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children
Occup. Environ. Med., July 1, 2004; 61(7): 609 - 615.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
C M Wilson, S E Bakewell, M R Miller, N D Hart, R C N McMorrow, P W Barry, D J Collier, S J Watt, and A J Pollard
Increased resting bronchial tone in normal subjects acclimatised to altitude
Thorax, May 1, 2002; 57(5): 400 - 404.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the European Respiratory Society.